Eleanor Stead

Eleanor Stead

Investment Analyst

About Eleanor

Eleanor is an investment analyst for Cancer Research Horizons. She identifies and evaluates oncology investment opportunities for the Seed Fund across therapeutics, medtech, and data and AI. She leads scientific and commercial due diligence on prospective investments, working closely with founders to understand their technology, strategy and growth plans. Eleanor also supports Cancer Research UK researchers exploring spin-out opportunities in collaboration with colleagues across translation teams and the wider innovation ecosystem. 

Eleanor joined Cancer Research Horizons in 2021 as a Business Development Manager, conducting data licensing partnerships with AI and techbio companies. She subsequently moved to CRUK to shape the charity's new ambition for children and young people's cancers, before joining the Ventures team in 2025. Prior to this, she worked in life science strategy consulting and held research positions at the UCL Cancer Institute and AstraZeneca. Eleanor holds a PhD in cancer biology and longevity from University College London.